INTERLEUKIN-6 (IL-6) AS AN ANTIINFLAMMATORY CYTOKINE - INDUCTION OF CIRCULATING IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-P55

被引：3
|
作者：
TILG, H
TREHU, E
ATKINS, MB
DINARELLO, CA
MIER, JW
机构：
[1] TUFTS UNIV NEW ENGLAND MED CTR,DEPT MED,DIV HEMATOL ONCOL,750 WASHINGTON ST,BOX 245,BOSTON,MA 02111
[2] TUFTS UNIV NEW ENGLAND MED CTR,DEPT MED,DIV GEOG MED & INFECT DIS,BOSTON,MA 02111
[3] TUFTS UNIV,SCH MED,BOSTON,MA 02111
来源：
BLOOD | 1994年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 118
页数：6
相关论文
共 50 条
  • [41] The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6
    Peters, M
    Jacobs, S
    Ehlers, M
    Vollmer, P
    Mullberg, J
    Wolf, E
    Brem, G
    zumBuschenfelde, KHM
    RoseJohn, S
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04): : 1399 - 1406
  • [42] DIFFERENTIAL INDUCTION OF THE INTERLEUKIN-6 GENE BY TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1
    NG, SB
    TAN, YH
    GUY, GR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (29) : 19021 - 19027
  • [43] NEUTRALIZATION OF ENDOGENOUS IL-6 SUPPRESSES INDUCTION OF IL-1 RECEPTOR ANTAGONIST
    JORDAN, M
    OTTERNESS, IG
    NG, R
    GESSNER, A
    ROLLINGHOFF, M
    BEUSCHER, HU
    JOURNAL OF IMMUNOLOGY, 1995, 154 (08): : 4081 - 4090
  • [44] INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR (TNF) INCREASE IN HYPOTHALAMUS OF RATS DURING LIPOPOLYSACCHARIDE (LPS)-INDUCED FEVER
    KLIR, JJ
    ROTH, J
    KLUGER, MJ
    FASEB JOURNAL, 1992, 6 (04): : A1200 - A1200
  • [45] TUMOR-NECROSIS-FACTOR (TNF) AND INTERLEUKIN-6 (IL-6) IN AGING MICE - EFFECT OF PERITONEAL STIMULUS ON MACROPHAGE PRODUCTION OF MONOKINES
    CHEN, Y
    MCFARLAND, M
    BRADLEY, S
    CLINICAL RESEARCH, 1991, 39 (02): : A392 - A392
  • [46] Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression
    März, P
    Heese, K
    Dimitriades-Schmutz, B
    Rose-John, S
    Otten, U
    GLIA, 1999, 26 (03) : 191 - 200
  • [47] ENDOTOXIN (ETX), TUMOR-NECROSIS-FACTOR (TNF-ALPHA) AND INTERLEUKIN-6 (IL-6) IN CIRRHOSIS WITH INFECTED AND NONINFECTED ASCITES
    NAVASA, M
    FRANCITORRA, A
    FOLLO, A
    ARROYO, V
    FILELLA, X
    JIMENEZ, W
    RIMOLA, A
    RODES, J
    HEPATOLOGY, 1993, 18 (04) : A104 - A104
  • [48] Analysis of tumor necrosis factor-α, interleukin-6, interleukin-1β, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders
    Kaneyama, K
    Segami, N
    Sun, W
    Sato, J
    Fujimura, K
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2005, 99 (03): : 276 - 284
  • [49] Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 receptor (sIL-6R) in patients with multiple myeloma
    Urbanska-Rys, H
    Wierzbowska, A
    Stepien, H
    Robak, T
    EUROPEAN CYTOKINE NETWORK, 2000, 11 (03) : 443 - 451
  • [50] DIFFERENCES IN INTERLEUKIN-1 (IL-1), IL-6, TUMOR-NECROSIS-FACTOR AND IL-1 RECEPTOR ANTAGONIST PRODUCTION BY HUMAN MONOCYTES STIMULATED WITH MURAMYL DIPEPTIDE (MDP) AND ITS STEAROYL DERIVATIVE, ROMURTIDE
    SUZUKI, K
    TORII, K
    HIDA, S
    HAYASHI, H
    HIYAMA, Y
    OOMOTO, Y
    TAKII, T
    CHIBA, T
    ONOZAKI, K
    IMMUNOPHARMACOLOGY, 1994, 28 (01): : 31 - 38
12345